|
Dr. Griffin currently serves as President of Griffin & Schwartz, Inc., a firm he founded in 1982 to provide consulting and management services to pharmaceutical and medical device companies. Clients include a number of development-stage companies as well as various investment entities. Concurrently, Dr. Griffin has served as President and Chief Executive Officer of POINT Biomedical Corporation, a development-stage specialty pharmaceutical company, and has served on the senior management team of InControl, another development-stage company engaged in bringing an implantable cardiac rhythm management device to market. He was also a professor of medicine and associate professor of medicine at the University of California at San Francisco from 1984-1992, an assistant professor of medicine for Baylor College of Medicine from 1981-1984, and clinical and acting assistant professor of medicine at Stanford University from 1978-1981. | 